查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1478704

脂质奈米颗粒原料市场、占有率、规模、趋势、产业分析报告：依产品、适应症、应用、最终用途、地区、细分市场预测，2024-2032 年

Lipid Nanoparticle Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Ionizable lipids, Reagents, Other raw materials); By Disease Indication; By Application; By End-use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research最新研究显示，到2032年，全球脂质奈米颗粒原料市场规模预计将达到3.3385亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

对脂质奈米颗粒原料的需求不断增长，很大程度上是由于对疫苗开发的日益关注。世界人口正在目睹慢性健康问题显着增加，特别是癌症和血液适应疾病。因此，医学研究人员面临着在市场上开发有效的诊断和治疗程序的压力，这将极大地促进对脂质奈米颗粒原料的需求。例如，2023年10月，生物医学研究所的研究人员宣布开发出一种用于结肠炎相关癌症的口服液态奈米颗粒药物。

新研究机构的不断发展正在对全球脂质奈米颗粒原料市场产生最佳影响。例如，2023年9月，Centre for Process Innovation将在英国引入Center of Excellence RNA，旨在生产用于临床试验的脂质奈米颗粒和RNA。此外，从长远来看，政府增加投资和补贴以促进科学发展可能会进一步促进脂质奈米粒子的生产，特别是解决疫苗不足的问题。例如，2023 年 9 月，Centre of Excellence RNA获得了 2,600 万英镑的资金，以支持开展 RNA 生产和开发活动的公司。

此外，正在进行的产品发布支持了用于製造疫苗、细胞和基因疗法的脂质奈米粒子的开发进展。例如，2024年4月，Cayman Chemicals宣布推出LipidLaunch研究工具，该工具有潜力发现脂质奈米颗粒。进一步的研究创新可能会揭示脂质奈米颗粒的真正潜力，并在研究期间推动市场成长。例如，《Nature Communication》2024 年发表的一项研究开发了一种使用奈米颗粒的靶向肺载体系统。

此外，研究人员为提高脂质奈米颗粒的生产能力而付出的努力可能会推动脂质奈米颗粒原料市场的成长。例如，2023 年 8 月，研究人员宣布推出一个新平台，可实现脂质奈米颗粒疫苗（SARS-CoV-2 mRNA）的高生产率。

脂质奈米颗粒原料市场报告亮点

由于其负担能力和研究活动的灵活性，套件部分预计将出现最高的增长。

由于传染病引起的健康问题越来越多，传染病细分市场占据最大的市场。

由于治疗方法开发的进步，预计治疗部门将占收入的更大占有率。

预计亚太地区将在预测期内实现最快的成长。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球脂质奈米颗粒原料市场洞察

  • 使用情况快照
  • 脂质奈米颗粒原料市场动态
    • 驱动因素和机遇
      • 肺部适应疾病的发生率增加
      • 多种治疗配方中更多采用 mRNA 技术
    • 限制因素和课题
      • 复杂的生产过程可能会阻碍市场成长
  • PESTEL 分析
  • 脂质奈米粒原料市场应用趋势
  • 价值链分析
  • COVID-19 影响分析

第五章 全球脂质奈米颗粒原料市场：依适应症分类

  • 主要发现
  • 介绍
  • 癌症
  • 感染
  • 血液适应病
  • 其他

第六章全球脂质奈米颗粒原料市场：副产品

  • 主要发现
  • 介绍
  • 成套工具
  • 试剂
  • 其他

第七章 全球脂质奈米颗粒原料市场：依应用分类

  • 主要发现
  • 介绍
  • 治疗
  • 研究

第八章全球脂质奈米颗粒原料市场：依地区

  • 主要发现
  • 介绍
    • 脂质奈米颗粒原料市场评估：依地区，2019-2032
  • 北美
    • 北美：依疾病适应症分类，2019-2032
    • 北美：依申请划分，2019-2032
    • 北美：依产品分类，2019-2032
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲：依适应症分类，2019-2032
    • 欧洲：依申请划分，2019-2032
    • 欧洲：依产品分类，2019-2032
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区：依疾病适应症分类，2019-2032
    • 亚太地区：依应用划分，2019-2032
    • 亚太地区：依产品分类，2019-2032
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印度尼西亚
    • 韩国
  • 中东/非洲
    • 中东和非洲：依疾病分类，2019-2032
    • 中东和非洲：依申请划分，2019-2032
    • 中东和非洲：依产品分类，2019-2032
    • 沙乌地阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疾病分类，2019-2032
    • 拉丁美洲：依应用划分，2019-2032
    • 拉丁美洲：依产品分类，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 获得
  • 伙伴关係/协作/协议/揭露

第十章公司简介

  • Avanti Polar Lipids（美国）
  • .Biopharma PEG Scientific Inc.（美国）
  • BroadPharm（美国）
  • CordenPharma International（德国）
  • Creative Biolabs（美国）
  • Echelon Biosciences（美国）
  • Merck KGaA（德国）
  • NOF AMERICA CORPORATION（美国）
  • Polysciences, Inc.（美国）
  • Tebu Bio（法国）
Product Code: PM4891

The global lipid nanoparticle raw materials market size is expected to reach USD 333.85 million by 2032, according to a new study by Polaris Market Research. The report "Lipid Nanoparticle Raw Materials Market Share, Size, Trends, Industry Analysis Report, By Product (Ionizable lipids, Reagents, Other raw materials); By Disease Indication; By Application; By End-use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for the lipid nanoparticle raw materials is highly attributable to the increasing focus on vaccination development. The worldwide population is witnessing a significant surge in chronic health issues, specifically cancer and blood diseases. This is enforcing healthcare researchers to formulate effective diagnosis and treatment procedures in the marketplace, which will significantly facilitate the need for lipid nanoparticle raw materials. For instance, in October 2023, the researchers at the Institute for Biomedical Science announced the development of an oral liquid nanoparticle drug for colitis-associated cancer.

The increasing development of new research institutes is optimally influencing the global lipid nanoparticle raw material market. For instance, in September 2023, Centre for Process Innovation introduced the Center of Excellence RNA in the UK, aiming to produce lipid nanoparticles and RNA for clinical trials. Additionally, the rising investments and grants by the government to fuel scientific developments, specifically to address the problem of inadequate vaccines, will further fuel the production of lipid nanoparticles in the long run. For instance, in September 2023, the RNA Centre of Excellence received funding of GBP 26 million to assist companies in the production and development activities of RNA.

Furthermore, the ongoing product launches are supporting advancements in the development of lipid nanoparticles for the manufacturing of vaccines, cell and gene therapies. For instance, in April 2024, Cayman Chemicals introduced the LipidLaunch research tools that have the potential to discover lipid nanoparticles. The growing research innovations unravel the true potential of the lipid nanoparticles, which will likely drive market growth during the study period. For instance, a 2024 study published in Nature Communication developed the targeted lung carrier system with the use of nanoparticles.

Additionally, the rising efforts taken by the researchers to increase the production capacity of lipid nanoparticles are likely to drive the growth of the lipid nanoparticle raw material market. For instance, in August 2023, researchers unveiled the launch of a new platform that enables a higher rate of production of lipid nanoparticle vaccines (SARS-CoV-2 mRNA).

Lipid Nanoparticle Raw Materials Market Report Highlights

Kits segment is anticipated to witness the highest growth due to its affordability and flexibility in research activities.

Infectious disease segment accounted for the largest market share owing to the increasing number of health issues due to infections.

Therapeutics segment is projected to experience a larger revenue share due to the growing development of therapies.

APAC is projected to register the fastest growth during the forecast period, attributable to the increasing blood cancer rate in the region.

The global players include Avanti Polar Lipids, Biopharma PEG Scientific Inc., BroadPharm, CordenPharma International, Creative Biolabs, & Echelon Biosciences.

Polaris Market Research has segmented the lipid nanoparticle raw materials market report based on product, disease indication, application, end-use, and region:

Lipid Nanoparticle Raw Materials, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Ionizable lipids
  • PEGylated lipids
  • Sterol lipids
  • Neutral phospholipids
  • Kits
  • Reagents
  • Other raw materials

Lipid Nanoparticle Raw Materials, Disease Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • Cancer
  • Infectious Diseases
  • Blood Diseases
  • Others

Lipid Nanoparticle Raw Materials, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Therapeutics
  • Research

Lipid Nanoparticle Raw Materials, End-use Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

Lipid Nanoparticle Raw Materials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lipid Nanoparticle Raw Materials Market Insights

  • 4.1. Lipid Nanoparticle Raw Materials Market - Application Snapshot
  • 4.2. Lipid Nanoparticle Raw Materials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidence of lung diseases
      • 4.2.1.2. Increasing adoption of mRNA technology in multiple therapeutic formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex production process is likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lipid Nanoparticle Raw Materials Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • 5.3. Cancer
    • 5.3.1. Global Lipid Nanoparticle Raw Materials Market, by Cancer, by Region, 2019-2032 (USD Million)
  • 5.4. Infectious Diseases
    • 5.4.1. Global Lipid Nanoparticle Raw Materials Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
  • 5.5. Blood Diseases
    • 5.5.1. Global Lipid Nanoparticle Raw Materials Market, by Blood Diseases, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Lipid Nanoparticle Raw Materials Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Lipid Nanoparticle Raw Materials Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 6.3. Ionizable lipids
    • 6.3.1. Global Lipid Nanoparticle Raw Materials Market, by Ionizable lipids, by Region, 2019-2032 (USD Million)
  • 6.4. Reagents
    • 6.4.1. Global Lipid Nanoparticle Raw Materials Market, by Reagents, by Region, 2019-2032 (USD Million)
  • 6.5. Other raw materials
    • 6.5.1. Global Lipid Nanoparticle Raw Materials Market, by Other raw materials, by Region, 2019-2032 (USD Million)

7. Global Lipid Nanoparticle Raw Materials Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • 7.3. Therapeutics
    • 7.3.1. Global Lipid Nanoparticle Raw Materials Market, by Therapeutics, By Region, 2019-2032 (USD Million)
  • 7.4. Research
    • 7.4.1. Global Lipid Nanoparticle Raw Materials Market, by Research, By Region, 2019-2032 (USD Million)

8. Global Lipid Nanoparticle Raw Materials Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Lipid Nanoparticle Raw Materials Market - North America
    • 8.3.1. North America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.3.2. North America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.3.3. North America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.3.4. Lipid Nanoparticle Raw Materials Market - U.S.
      • 8.3.4.1. U.S.: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.3.5. Lipid Nanoparticle Raw Materials Market - Canada
      • 8.3.5.1. Canada: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.4. Lipid Nanoparticle Raw Materials Market - Europe
    • 8.4.1. Europe: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.4.3. Europe: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.4. Lipid Nanoparticle Raw Materials Market - UK
      • 8.4.4.1. UK: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.4.3. UK: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.5. Lipid Nanoparticle Raw Materials Market - France
      • 8.4.5.1. France: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.5.3. France: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.6. Lipid Nanoparticle Raw Materials Market - Germany
      • 8.4.6.1. Germany: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.7. Lipid Nanoparticle Raw Materials Market - Italy
      • 8.4.7.1. Italy: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.8. Lipid Nanoparticle Raw Materials Market - Spain
      • 8.4.8.1. Spain: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.9. Lipid Nanoparticle Raw Materials Market - Netherlands
      • 8.4.9.1. Netherlands: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.4.10. Lipid Nanoparticle Raw Materials Market - Russia
      • 8.4.10.1. Russia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.5. Lipid Nanoparticle Raw Materials Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.4. Lipid Nanoparticle Raw Materials Market - China
      • 8.5.4.1. China: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.4.3. China: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.5. Lipid Nanoparticle Raw Materials Market - India
      • 8.5.5.1. India: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.5.3. India: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.6. Lipid Nanoparticle Raw Materials Market - Malaysia
      • 8.5.6.1. Malaysia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.7. Lipid Nanoparticle Raw Materials Market - Japan
      • 8.5.7.1. Japan: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.8. Lipid Nanoparticle Raw Materials Market - Indonesia
      • 8.5.8.1. Indonesia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.5.9. Lipid Nanoparticle Raw Materials Market - South Korea
      • 8.5.9.1. South Korea: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.6. Lipid Nanoparticle Raw Materials Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.4. Lipid Nanoparticle Raw Materials Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.5. Lipid Nanoparticle Raw Materials Market - UAE
      • 8.6.5.1. UAE: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.6. Lipid Nanoparticle Raw Materials Market - Israel
      • 8.6.6.1. Israel: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.6.7. Lipid Nanoparticle Raw Materials Market - South Africa
      • 8.6.7.1. South Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • 8.7. Lipid Nanoparticle Raw Materials Market - Latin America
    • 8.7.1. Latin America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
    • 8.7.3. Latin America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.4. Lipid Nanoparticle Raw Materials Market - Mexico
      • 8.7.4.1. Mexico: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.5. Lipid Nanoparticle Raw Materials Market - Brazil
      • 8.7.5.1. Brazil: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
    • 8.7.6. Lipid Nanoparticle Raw Materials Market - Argentina
      • 8.7.6.1. Argentina: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Avanti Polar Lipids (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Biopharma PEG Scientific Inc. (US)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BroadPharm (US)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. CordenPharma International (Germany)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Creative Biolabs (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Echelon Biosciences (US)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck KGaA (Germany)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. NOF AMERICA CORPORATION (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Polysciences, Inc. (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Tebu Bio (France)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 2 Global Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 3 Global Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 4 Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 6 North America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 7 North America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 8 U.S.: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 10 U.S.: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 11 Canada: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 12 Canada: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 13 Canada: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 14 Europe: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 15 Europe: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 16 Europe: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 17 UK: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 18 UK: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 19 UK: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 20 France: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 21 France: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 22 France: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 23 Germany: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 24 Germany: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 25 Germany: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 26 Italy: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 27 Italy: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 28 Italy: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 29 Spain: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 30 Spain: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 31 Spain: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 32 Netherlands: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 33 Netherlands: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 34 Netherlands: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 35 Russia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 36 Russia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 37 Russia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 41 China: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 42 China: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 43 China: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 44 India: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 45 India: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 46 India: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 47 Malaysia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 48 Malaysia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 49 Malaysia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 50 Japan: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 51 Japan: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 52 Japan: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 53 Indonesia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 54 Indonesia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 55 Indonesia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 56 South Korea: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 57 South Korea: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 58 South Korea: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 65 UAE: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 66 UAE: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 67 UAE: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 68 Israel: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 69 Israel: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 70 Israel: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 71 South Africa: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 72 South Africa: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 73 South Africa: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 74 Latin America: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 75 Latin America: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 76 Latin America: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 77 Mexico: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 78 Mexico: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 79 Mexico: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 80 Brazil: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 81 Brazil: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 82 Brazil: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)
  • Table 83 Argentina: Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2019-2032 (USD Million)
  • Table 84 Argentina: Lipid Nanoparticle Raw Materials Market, by Product, 2019-2032 (USD Million)
  • Table 85 Argentina: Lipid Nanoparticle Raw Materials Market, by Application , 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Lipid Nanoparticle Raw Materials Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Lipid Nanoparticle Raw Materials Market, by Product, 2022 & 2032 (USD Million)
  • Figure 8. Market by Disease Indication
  • Figure 9. Global Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2022 & 2032 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Lipid Nanoparticle Raw Materials Market, by Application , 2022 & 2032 (USD Million)
  • Figure 12. Lipid Nanoparticle Raw Materials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Lipid Nanoparticle Raw Materials Market